ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

Coagulation and Natural Anticoagulants

Theme Navigation

  • ISTH 2022 Congress
    • Coagulation and Natural Anticoagulants
      • Animal Models in Thrombosis and Hemostasis
      • Coagulation Factors and Inhibitors
      • Contact Pathway
      • Critical Care and Perioperative
      • FVIII/IX
      • Hemostasis and Organ Dysfunction
      • Microparticles
      • Protein C Pathway
      • Regulation of Coagulation
      • Tissue Factor Pathway

Abstract Number: OC 44.3

A new mouse model of impaired fibrin α-chain crosslinking shows increased venous thrombembolism

C. Duval1, T. Feller2, H. mcPherson1, R. Ariëns3

Abstract Number: OC 65.3

A Phase 2 Trial Evaluating the Safety and Antithrombotic Efficacy of AB002, a First-in-class Protein C Activator in End-stage Renal Disease Patients on Heparin-free Hemodialysis

N. Verbout1, C. Lorentz1, B. Markway1, M. Wallisch1, J. Shatzel2, E. Tucker1

Abstract Number: PB0552

A Probable Therapeutic for a Child with Inherited Protein S Deficiency

V. Pereira1, L. Thangada2, M. khosla3, r. majumder4

Abstract Number: VPB0572

A study of the stability of fibrinogen and FXIII levels and microbial integrity of pooled cyroprecipitate stored at 1-6°C and 20-24°C for up to 120 hours

H. Kaur1, A. Ang1, S. Chua1, P. Shu1, C. Tan2, W. Wong2

Abstract Number: OC 36.4

A Tethered Artificial Protease Reveals the Location of Key Regulatory Motifs in Factor V

F. Ayombil1, R. Toso1, R. Camire2

Abstract Number: PB0548

Abelacimab, a Factor XI/XIa Antibody Inhibits Clotting in Hemodialysis Circuits Ex Vivo

K. Kovacevic1, C. Schörgenhofer2, G. Langer2, Y. Khder3, B. Jilma2, J. Grafeneder4

Abstract Number: OC 44.1

Activation of the Plasma Contact System Triggers the Fat Embolism Syndrome

S. Konrath1, S. Hemkemeyer1, R. Mailer1, K. Püschel1, B. Ondruschka1, T. Renné2

Abstract Number: OC 03.5

An Integrative Biology Approach to Model the Role of the Feedback Activation of FXI by Thrombin in the Tissue Factor Pathway

H. Lakshmanan1, A. Estonilo2, S. Reitsma3, A. Melrose3, T. Zheng3, J. Maddala4, D. Gailani5, P. Jurney2, C. Puy3, O. McCarty6

Abstract Number: OC 36.3

Analysis of TFPI-protein S anticoagulant function in vivo.

A. Petri1, P. Sasikumar1, P. Badia Folgado1, D. Jones2, J. Ahnström1, I. Salles-Crawley3, J. Crawley1

Abstract Number: OC 65.2

Andexanet alfa is associated with a significant reduction in in-hospital mortality compared to 4F-PCC in a real-world analysis

P. Dobesh1, C. Coleman2, J. Ulloa3, B. Lovelace4, T. Dettling4, B. Koch4, G. Fermann5

Abstract Number: LB 01.5

Antiplatelet effects of inhibiting coagulation factor XI in a non-human primate model of atherosclerosis

H. Vu1, T. Kohs1, J. Pang1, K. Jordan1, T. Zheng1, P. Kievit2, J. Johnson1, M. Wallisch3, M. Hinds1, C. Puy1, C. Lorentz3, E. Tucker4, D. Gailani5, J. Aslan1, J. Shatzel1, O. McCarty6, I. Parra-Izquierdo1

Abstract Number: OC 67.1

Antithrombin deficiency and altered heparin responsiveness during veno-arterial extracorporeal life support: a prospective study

A. Mansour1, M. Berahou2, J. Odot2, A. Pontis3, F. NEDELEC-GAC4, A. Parasido5, F. Reizine6, Y. Launey2, A. Ousmen7, R. Garlantezec7, E. Flecher5, N. Nesseler8, I. Gouin9

Abstract Number: PB0547

Antithrombin deficiency is associated with more compact plasma fibrin clot structure and impaired susceptibility to fibrinolysis

A. Klajmon1, M. Kopytek2, J. Natorska3, A. Undas1, M. Ząbczyk3

Abstract Number: PB1016

Argatroban Monitoring in Critically Ill Patients and correlation with Thrombin Generation

G. Scheriau1, C. Schkömmer1, L. Wagner2, N. Binder2, B. Steinlechner3

Abstract Number: VPB1019

Assessing the reversal efficacy of prothrombin complex concentrate (PCC) and andexanet alfa in rivaroxaban-anticoagulated blood: Ex vivo study

F. Rayatdoost1, K. Deventer1, H. Schöchl2, O. Grottke1

Abstract Number: VPB0570

Assessment of Impact of Metabolites of Edoxaban and Dabigatran on Fibrin and Thrombin Generation Assays

J. Evrard1, R. Siriez1, V. Maloteau1, J. Dogné2, J. Douxfils3

Abstract Number: PB1015

Assessment of Quantra Analyzer on life-threating bleeding under oral anticoagulants agents: a pilot study

D. Teissandier1, C. Lucchini2, J. Bouillon-Minois3, J. Schmidt4, T. Sinegre5, c. Morand6, A. Lebreton7, F. Moustafa4

Abstract Number: PB0542

Bio-equivalence of Potency adjusted approved heparin solutions compared to a newly developed heparin solution.

E. Krupa1, D. Hoppensteadt2, W. Jeske1, A. Farooqui1, A. Kouta1, O. Iqbal1, B. Kantarcioglu3, R. Krämer4, J. Fareed2

Abstract Number: PB1050

Blockade of K-ras signalling prevents coagulatory phenotype of alternatively activated macrophages.

P. Haider1, J. Kral-Pointner2, M. Salzmann2, B. Podesser3, J. Wojta2, P. Hohensinner3

Abstract Number: OC 03.3

Bradykinin Liberation from High Molecular Weight Kininogen by Plasma Kallikrein on Endothelial Cell Membranes is Modulated by Ambient Concentration of C1 inhibitor and Prolylcarboxypeptidase

A. Merkulova1, S. Abdalian2, G. Forbes3, P. Zeng3, A. Pinheiro3, A. Schmaier4

  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »

« View all themes from the ISTH 2022 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley